These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1746154)
1. Factors involved in immunity against Actinobacillus pleuropneumoniae in mice. Bhatia B; Mittal KR; Frey J Vet Microbiol; 1991 Oct; 29(2):147-58. PubMed ID: 1746154 [TBL] [Abstract][Full Text] [Related]
2. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B. Jolie RA; Mulks MH; Thacker BJ Vet Microbiol; 1995 Aug; 45(4):383-91. PubMed ID: 7483251 [TBL] [Abstract][Full Text] [Related]
3. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model. Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs. Bei W; He Q; Zhou R; Yan L; Huang H; Chen H Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102 [TBL] [Abstract][Full Text] [Related]
5. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. van den Bosch H; Frey J Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088 [TBL] [Abstract][Full Text] [Related]
7. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination. Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs. Oishi E; Kitajima T; Koyama Y; Ohgitani T; Katayama S; Okabe T J Vet Med Sci; 1995 Dec; 57(6):1125-8. PubMed ID: 8720063 [TBL] [Abstract][Full Text] [Related]
9. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs. Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246 [TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae. Byrd W; Harmon BG; Kadis S Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199 [TBL] [Abstract][Full Text] [Related]
12. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71. Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins. Madsen ME; Carnahan KG; Thwaits RN FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344 [TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983 [TBL] [Abstract][Full Text] [Related]
15. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae. Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060 [TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of cell-free-antigen of Actinobacillus pleuropneumoniae in mice. Oishi E; Kitajima T; Ohgitani T; Katayama S; Okabe T J Vet Med Sci; 1995 Aug; 57(4):727-31. PubMed ID: 8519906 [TBL] [Abstract][Full Text] [Related]
17. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge. Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888 [TBL] [Abstract][Full Text] [Related]
18. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae. Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157 [TBL] [Abstract][Full Text] [Related]
19. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines. Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941 [TBL] [Abstract][Full Text] [Related]
20. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison. Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]